Posts

2021-like North American heat extremes: Increased impac...

In 2021, North America experienced one of the deadliest heatwaves in history, wi...

Mathematical model provides bolt of understanding for l...

UNIVERSITY PARK, Pa. — In the early 2000s, scientists observed lightning dischar...

New study offers clues to how cancer spreads to the brain

March 31, 2023 Credit: Wiley March 31, 2023 For more information, contact: Nicol...

The Institut Pasteur and the University of São Paulo si...

On Friday March 31st, 2023 at a ceremony in Paris, the Institut Pasteur Presiden...

Harnessing nature to promote planetary sustainability

As Earth’s population grows, the demands of modern lifestyles place mounting str...

Study shows ketamine could be beneficial for treating b...

A common anesthesia drug could be beneficial in reducing pressure inside the sku...

Metformin & leucine prevent cellular senescence & prote...

“Cellular senescence and disrupted proteostasis induced by myotube atrophy are p...

Plastic transistor amplifies biochemical sensing signal

EVANSTON, Ill. — The molecules in our bodies are in constant communication. Some...

Cookin’ with gas: UWO professor earns patent for flamel...

Pawel Olszewski, a University of Wisconsin Oshkosh associate mechanical engineer...

After spinal cord injury, kinesthetic sense helps resto...

For nearly 50 years, a jawless fish called the lamprey has interested scientists...

Final Human Brain Project Summit closes with a vision f...

The ten-year European Flagship Human Brain Project (HBP) links brain research wi...

Small and medium biotechs jump on obesity train

Small and medium biotechs join the hunt for new obesity therapies amidst a backd...

Hipra’s Covid-19 booster gets EMA nod and enters an unc...

As the EMA recommends Bimervax's as a booster, global plans for Covid-19 vaccin...

Medicines Patent Pool broadens access to generic inject...

The agreements could broaden the access to the GSK/ViiV’s long-acting PrEP in lo...

GSK signs licence deal with Scynexis for fungal infecti...

Ibrexafungerp is now being evaluated in Phase III clinical trials to treat invas...

Moderna to set up new mRNA manufacturing facility in Kenya

The facility is expected to enable manufacturing of drug products for Kenya and ...